CDK7-IN-22

• Description:

  CDK7-IN-22 (compound 101) is an CDK7 inhibitor with antitumor activity. CDK7-IN-22 shows selectivity on CDK7[1].

• UNSPSC:

  12352005

• Target:

  CDK

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/cdk7-in-22.html

• Solubility:

  10 mM in DMSO

• Smiles:

  FC (F) (C1=CN=C (N[C@H]2CCCNC2) N=C1C3=CNC4=CC (N5CCCC5) =CC=C34) F

• Molecular Formula:

  C22H25F3N6

• Molecular Weight:

  430.47

• References & Citations:

  [1]Gu Xiaohui, et al. 、. TW110134941A.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  2173190-60-6